Cancer Immunotherapy in Combination with Radiotherapy and/or Chemotherapy: Mechanisms and Clinical Therapy
ABSTRACT Since the United States Food and Drug Administration approved the first immune checkpoint inhibitor ipilimumab for metastatic melanoma in 2011, ICIs have been approved for a range of cancers and significantly improving treatment outcomes. However, the objective response rate of ICI monother...
Na minha lista:
| Principais autores: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Wiley
2025-09-01
|
| coleção: | MedComm |
| Assuntos: | |
| Acesso em linha: | https://doi.org/10.1002/mco2.70346 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|